CVS Health Corp is a diversified healthcare company that operates a vast network of retail pharmacies, providing prescription medications, over-the-counter products, and health and wellness services
In addition to its retail operations, CVS Health also offers pharmacy benefit management services, helping manage prescription drug costs for businesses and health plans. The company is involved in providing health insurance and health services through its various divisions, including a growing presence in digital health solutions and immunization services. By integrating pharmacy services with healthcare delivery, CVS Health aims to enhance patient care and improve health outcomes across the communities it serves.
CVS Health has had an impressive run over the past six months as its shares have beaten the S&P 500 by 11.4%. The stock now trades at $65.60, marking a 15.2% gain. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
Speculation over an impending reverse merger, a Phase 2 trial announcement, comments about upcoming cancer screening tests, a Medicare business deal, and an obesity drug partnership sparked buzz among Stocktwits users for the week ended March 7, 2025.
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US.
The Justice Department is investigating UnitedHealth's Medicare billing practices, focusing on diagnoses that led to higher federal payments. The probe follows reports that the company received billions for questionable diagnoses in its Medicare Advantage plans.
Humana is the second largest health insurance provider of Medicare Advantage (MA) plans sounding the alarms of rising medical costs but will now cut 10%
In the last week, these 13 large-cap stocks were top performers. Are they in your portfolio? HIMS, AUR, APP, SMCI, TEM, DKNG, INTC, MNDY, BROS, CVS, BABA, AAPL, ABNB.
CVS Health exceeded Q4 sales estimates with $97.71B revenue. The company projects 2025 revenue above $134B and expects Medicare Advantage margins to improve.
